세계의 메디컬 라이팅 분야 인공지능(AI) 시장 규모, 점유율, 동향 분석 보고서 : 유형별, 최종 용도별, 지역별 전망 및 예측(2024-2031년)
Global AI In Medical Writing Market Size, Share & Trends Analysis Report By Type, By End Use (Pharmaceutical, Biotechnology, Medical Devices, and Other End Use), By Regional Outlook and Forecast, 2024 - 2031
메디컬 라이팅 분야 인공지능(AI) 시장 규모는 예측 기간 동안 12.2%의 연평균 복합 성장률(CAGR)로 성장하여 2031년까지 17억 2,000만 달러에 달할 것으로 예상됩니다.
또한, 전 세계적으로 임상시험이 확대됨에 따라 프로토콜, 시험 결과, 규제 제출 서류 등에 대한 상세하고 정확한 문서화의 필요성이 증가하고 있습니다. 특히 신흥 시장에서는 임상시험이 더욱 복잡하고 광범위해지면서 생성되는 데이터의 양이 크게 증가하고 있습니다.
그러나 AI를 활용한 솔루션을 의학 논문 작성 프로세스에 통합하는 데는 상당한 비용이 소요됩니다. 이러한 비용에는 고급 AI 알고리즘 개발, 강력한 컴퓨팅 인프라 확보, 지속적인 유지보수 등이 포함됩니다. 또한, 기업은 이러한 시스템을 효과적으로 관리하고 최적화하기 위해 숙련된 인력을 고용하고 교육하는 데 투자해야 합니다. 그 결과, 많은 중소기업은 전통적인 방법에 의존하여 AI 기반 시스템이 가져올 수 있는 잠재적인 효율성과 정확성 향상을 놓치고 있습니다. 따라서 이러한 확장으로 인해 정확하고 효율적인 문서의 중요성이 강조되면서 의료 문서 작성 솔루션에서 AI에 대한 수요가 증가하고 있습니다.
유형 전망
유형에 따라 시장은 임상 작문, 타이핑, 과학 작문, 기타로 분류됩니다. 과학 작문 부문은 2023년 시장에서 27%의 매출 점유율을 차지할 것으로 예상됩니다. 이 부문은 고품질의 데이터 기반 의료 연구 및 학술 컨텐츠에 대한 수요가 증가함에 따라 유리한 위치를 점하고 있습니다.
최종 용도 전망
최종 용도에 따라 시장은 의료기기, 제약, 생명 공학 및 기타로 분류됩니다. 제약 부문은 2023년 시장에서 32%의 매출 점유율을 차지할 것으로 예상됩니다. 제약 부문은 주로 규제 준수에 대한 수요 증가와 임상시험, 의약품 개발 및 안전성 보고를 위한 광범위한 문서 관리의 필요성에 의해 주도되고 있습니다.
지역 전망
지역별로는 북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카로 시장을 분석했습니다. 아시아태평양 부문은 2023년 시장에서 28%의 매출 점유율을 기록했습니다. 아시아태평양은 특히 중국, 인도, 일본과 같은 신흥국의 제약 및 헬스케어 분야의 급속한 성장에 의해 주도되고 있습니다.
목차
제1장 시장 범위와 조사 방법
- 시장의 정의
- 목적
- 시장 범위
- 세분화
- 조사 방법
제2장 시장 요람
제3장 시장 개요
- 서론
- 시장에 영향을 미치는 주요 요인
- 시장 성장 촉진요인
- 시장 성장 억제요인
- 시장 기회
- 시장이 해결해야 할 과제
제4장 경쟁 분석 - 세계
- 시장 점유율 분석, 2023년
- 메디컬 라이팅 분야 인공지능(AI) 최신 전략
- Porter의 Five Forces 분석
제5장 세계 시장 : 유형별
- 세계의 타입 라이팅 시장 : 지역별
- 세계의 과학 라이팅 시장 : 지역별
- 세계의 임상 라이팅 시장 : 지역별
- 세계의 기타 유형 시장 : 지역별
제6장 세계 시장 : 최종 용도별
- 세계의 의약품 시장 : 지역별
- 세계의 바이오테크놀러지 시장 : 지역별
- 세계의 의료기기 시장 : 지역별
- 세계의 기타 최종 용도 시장 : 지역별
제7장 세계 시장 : 지역별
- 북미
- 유럽
- 유럽 시장 : 국가별
- 독일
- 영국
- 프랑스
- 러시아
- 스페인
- 이탈리아
- 기타 유럽
- 아시아태평양
- 아시아태평양 시장 : 국가별
- 중국
- 일본
- 인도
- 한국
- 싱가포르
- 말레이시아
- 기타 아시아태평양
- 라틴아메리카/중동 및 아프리카
- 라틴아메리카/중동 및 아프리카 시장 : 국가별
- 브라질
- 아르헨티나
- 아랍에미리트(UAE)
- 사우디아라비아
- 남아프리카공화국
- 나이지리아
- 기타 라틴아메리카/중동 및 아프리카
제8장 기업 개요
- Parexel International(MA) Corporation
- Certara, Inc
- Accenture PLC
- Smarter Dx, Inc
- Corti ApS
- IQVIA Holdings, Inc
- Abridge Al, Inc
- Syneos Health, Inc
- IBM Corporation
- Teladoc Health, Inc
제9장 메디컬 라이팅 분야 인공지능(AI) 성공 필수 조건
LSH
The Global AI In Medical Writing Market size is expected to reach $1.72 billion by 2031, rising at a market growth of 12.2% CAGR during the forecast period.
Canada is also embracing AI in medical writing as part of its broader investment in healthcare, which reached approximately CAD 331 billion in 2022, according to the Canadian Institute for Health Information (CIHI). Government initiatives like the "Canada Health Infoway" aim to enhance healthcare delivery through digital solutions, emphasizing personalized medicine that tailors treatments to individual patients. Thus, The North America segment garnered 35% revenue share in the market in 2023.
Adherence to stringent regulatory requirements is paramount in the pharmaceutical and healthcare industries. Regulatory bodies such as the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and others mandate detailed and accurate documentation for every stage of drug development, clinical trials, manufacturing, and post-market surveillance. Hence, the increasing need for regulatory compliance in the pharmaceutical and healthcare sectors has driven the adoption of AI-powered solutions.
Additionally, the global expansion of clinical trials drives the need for detailed and accurate documentation, including protocols, trial results, and regulatory submissions. As clinical trials become more complex and widespread, especially in emerging markets, the volume of data generated has significantly increased.
However, the integration of AI-powered solutions into medical writing processes comes with substantial financial requirements. These costs include developing sophisticated AI algorithms, acquiring robust computing infrastructure, and ongoing maintenance. Additionally, companies must often invest in hiring or training skilled personnel to manage and optimize these systems effectively. As a result, many SMEs rely on traditional methods, missing out on the potential efficiency and accuracy gains offered by AI-driven systems. Therefore, such expansion has underscored the importance of precise and efficient documentation, driving the demand for AI in medical writing solutions.
Type Outlook
Based on type, the market is classified into clinical writing, type writing, scientific writing, and others. The scientific writing segment procured 27% revenue share in the market in 2023. This segment is advantageous due to the increasing demand for high-quality, data-driven medical research and scholarly content.
End Use Outlook
On the basis of end use, the market is divided into medical devices, pharmaceutical, biotechnology, and others. The pharmaceutical segment acquired 32% revenue share in the market in 2023. The pharmaceutical segment is primarily driven by the rising demand for regulatory compliance and the need to manage extensive documentation for clinical trials, drug development, and safety reporting.
Regional Outlook
Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The Asia Pacific segment witnessed 28% revenue share in the market in 2023. The Asia-Pacific region is being propelled by the swift growth of the pharmaceutical and healthcare sectors, especially in developing countries like China, India, and Japan.
List of Key Companies Profiled
- Parexel International (MA) Corporation
- Certara, Inc.
- Accenture PLC
- Smarter Dx, Inc.
- Corti ApS
- IQVIA Holdings, Inc.
- Abridge Al, Inc.
- Syneos Health, Inc.
- IBM Corporation
- Teladoc Health, Inc.
Global AI In Medical Writing Market Report Segmentation
By Type
- Type Writing
- Scientific Writing
- Clinical Writing
- Other Type
By End Use
- Pharmaceutical
- Biotechnology
- Medical Devices
- Other End Use
By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
- LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Global AI In Medical Writing Market, by Type
- 1.4.2 Global AI In Medical Writing Market, by End Use
- 1.4.3 Global AI In Medical Writing Market, by Geography
- 1.5 Methodology for the research
Chapter 2. Market at a Glance
Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges
Chapter 4. Competition Analysis - Global
- 4.1 Market Share Analysis, 2023
- 4.2 Recent Strategies Deployed in AI In Medical Writing Market
- 4.3 Porter Five Forces Analysis
Chapter 5. Global AI In Medical Writing Market by Type
- 5.1 Global Type Writing Market by Region
- 5.2 Global Scientific Writing Market by Region
- 5.3 Global Clinical Writing Market by Region
- 5.4 Global Other Type Market by Region
Chapter 6. Global AI In Medical Writing Market by End Use
- 6.1 Global Pharmaceutical Market by Region
- 6.2 Global Biotechnology Market by Region
- 6.3 Global Medical Devices Market by Region
- 6.4 Global Other End Use Market by Region
Chapter 7. Global AI In Medical Writing Market by Region
- 7.1 North America AI In Medical Writing Market
- 7.1.1 North America AI In Medical Writing Market by Type
- 7.1.1.1 North America Type Writing Market by Country
- 7.1.1.2 North America Scientific Writing Market by Country
- 7.1.1.3 North America Clinical Writing Market by Country
- 7.1.1.4 North America Other Type Market by Country
- 7.1.2 North America AI In Medical Writing Market by End Use
- 7.1.2.1 North America Pharmaceutical Market by Country
- 7.1.2.2 North America Biotechnology Market by Country
- 7.1.2.3 North America Medical Devices Market by Country
- 7.1.2.4 North America Other End Use Market by Country
- 7.1.3 North America AI In Medical Writing Market by Country
- 7.1.3.1 US AI In Medical Writing Market
- 7.1.3.1.1 US AI In Medical Writing Market by Type
- 7.1.3.1.2 US AI In Medical Writing Market by End Use
- 7.1.3.2 Canada AI In Medical Writing Market
- 7.1.3.2.1 Canada AI In Medical Writing Market by Type
- 7.1.3.2.2 Canada AI In Medical Writing Market by End Use
- 7.1.3.3 Mexico AI In Medical Writing Market
- 7.1.3.3.1 Mexico AI In Medical Writing Market by Type
- 7.1.3.3.2 Mexico AI In Medical Writing Market by End Use
- 7.1.3.4 Rest of North America AI In Medical Writing Market
- 7.1.3.4.1 Rest of North America AI In Medical Writing Market by Type
- 7.1.3.4.2 Rest of North America AI In Medical Writing Market by End Use
- 7.2 Europe AI In Medical Writing Market
- 7.2.1 Europe AI In Medical Writing Market by Type
- 7.2.1.1 Europe Type Writing Market by Country
- 7.2.1.2 Europe Scientific Writing Market by Country
- 7.2.1.3 Europe Clinical Writing Market by Country
- 7.2.1.4 Europe Other Type Market by Country
- 7.2.2 Europe AI In Medical Writing Market by End Use
- 7.2.2.1 Europe Pharmaceutical Market by Country
- 7.2.2.2 Europe Biotechnology Market by Country
- 7.2.2.3 Europe Medical Devices Market by Country
- 7.2.2.4 Europe Other End Use Market by Country
- 7.2.3 Europe AI In Medical Writing Market by Country
- 7.2.3.1 Germany AI In Medical Writing Market
- 7.2.3.1.1 Germany AI In Medical Writing Market by Type
- 7.2.3.1.2 Germany AI In Medical Writing Market by End Use
- 7.2.3.2 UK AI In Medical Writing Market
- 7.2.3.2.1 UK AI In Medical Writing Market by Type
- 7.2.3.2.2 UK AI In Medical Writing Market by End Use
- 7.2.3.3 France AI In Medical Writing Market
- 7.2.3.3.1 France AI In Medical Writing Market by Type
- 7.2.3.3.2 France AI In Medical Writing Market by End Use
- 7.2.3.4 Russia AI In Medical Writing Market
- 7.2.3.4.1 Russia AI In Medical Writing Market by Type
- 7.2.3.4.2 Russia AI In Medical Writing Market by End Use
- 7.2.3.5 Spain AI In Medical Writing Market
- 7.2.3.5.1 Spain AI In Medical Writing Market by Type
- 7.2.3.5.2 Spain AI In Medical Writing Market by End Use
- 7.2.3.6 Italy AI In Medical Writing Market
- 7.2.3.6.1 Italy AI In Medical Writing Market by Type
- 7.2.3.6.2 Italy AI In Medical Writing Market by End Use
- 7.2.3.7 Rest of Europe AI In Medical Writing Market
- 7.2.3.7.1 Rest of Europe AI In Medical Writing Market by Type
- 7.2.3.7.2 Rest of Europe AI In Medical Writing Market by End Use
- 7.3 Asia Pacific AI In Medical Writing Market
- 7.3.1 Asia Pacific AI In Medical Writing Market by Type
- 7.3.1.1 Asia Pacific Type Writing Market by Country
- 7.3.1.2 Asia Pacific Scientific Writing Market by Country
- 7.3.1.3 Asia Pacific Clinical Writing Market by Country
- 7.3.1.4 Asia Pacific Other Type Market by Country
- 7.3.2 Asia Pacific AI In Medical Writing Market by End Use
- 7.3.2.1 Asia Pacific Pharmaceutical Market by Country
- 7.3.2.2 Asia Pacific Biotechnology Market by Country
- 7.3.2.3 Asia Pacific Medical Devices Market by Country
- 7.3.2.4 Asia Pacific Other End Use Market by Country
- 7.3.3 Asia Pacific AI In Medical Writing Market by Country
- 7.3.3.1 China AI In Medical Writing Market
- 7.3.3.1.1 China AI In Medical Writing Market by Type
- 7.3.3.1.2 China AI In Medical Writing Market by End Use
- 7.3.3.2 Japan AI In Medical Writing Market
- 7.3.3.2.1 Japan AI In Medical Writing Market by Type
- 7.3.3.2.2 Japan AI In Medical Writing Market by End Use
- 7.3.3.3 India AI In Medical Writing Market
- 7.3.3.3.1 India AI In Medical Writing Market by Type
- 7.3.3.3.2 India AI In Medical Writing Market by End Use
- 7.3.3.4 South Korea AI In Medical Writing Market
- 7.3.3.4.1 South Korea AI In Medical Writing Market by Type
- 7.3.3.4.2 South Korea AI In Medical Writing Market by End Use
- 7.3.3.5 Singapore AI In Medical Writing Market
- 7.3.3.5.1 Singapore AI In Medical Writing Market by Type
- 7.3.3.5.2 Singapore AI In Medical Writing Market by End Use
- 7.3.3.6 Malaysia AI In Medical Writing Market
- 7.3.3.6.1 Malaysia AI In Medical Writing Market by Type
- 7.3.3.6.2 Malaysia AI In Medical Writing Market by End Use
- 7.3.3.7 Rest of Asia Pacific AI In Medical Writing Market
- 7.3.3.7.1 Rest of Asia Pacific AI In Medical Writing Market by Type
- 7.3.3.7.2 Rest of Asia Pacific AI In Medical Writing Market by End Use
- 7.4 LAMEA AI In Medical Writing Market
- 7.4.1 LAMEA AI In Medical Writing Market by Type
- 7.4.1.1 LAMEA Type Writing Market by Country
- 7.4.1.2 LAMEA Scientific Writing Market by Country
- 7.4.1.3 LAMEA Clinical Writing Market by Country
- 7.4.1.4 LAMEA Other Type Market by Country
- 7.4.2 LAMEA AI In Medical Writing Market by End Use
- 7.4.2.1 LAMEA Pharmaceutical Market by Country
- 7.4.2.2 LAMEA Biotechnology Market by Country
- 7.4.2.3 LAMEA Medical Devices Market by Country
- 7.4.2.4 LAMEA Other End Use Market by Country
- 7.4.3 LAMEA AI In Medical Writing Market by Country
- 7.4.3.1 Brazil AI In Medical Writing Market
- 7.4.3.1.1 Brazil AI In Medical Writing Market by Type
- 7.4.3.1.2 Brazil AI In Medical Writing Market by End Use
- 7.4.3.2 Argentina AI In Medical Writing Market
- 7.4.3.2.1 Argentina AI In Medical Writing Market by Type
- 7.4.3.2.2 Argentina AI In Medical Writing Market by End Use
- 7.4.3.3 UAE AI In Medical Writing Market
- 7.4.3.3.1 UAE AI In Medical Writing Market by Type
- 7.4.3.3.2 UAE AI In Medical Writing Market by End Use
- 7.4.3.4 Saudi Arabia AI In Medical Writing Market
- 7.4.3.4.1 Saudi Arabia AI In Medical Writing Market by Type
- 7.4.3.4.2 Saudi Arabia AI In Medical Writing Market by End Use
- 7.4.3.5 South Africa AI In Medical Writing Market
- 7.4.3.5.1 South Africa AI In Medical Writing Market by Type
- 7.4.3.5.2 South Africa AI In Medical Writing Market by End Use
- 7.4.3.6 Nigeria AI In Medical Writing Market
- 7.4.3.6.1 Nigeria AI In Medical Writing Market by Type
- 7.4.3.6.2 Nigeria AI In Medical Writing Market by End Use
- 7.4.3.7 Rest of LAMEA AI In Medical Writing Market
- 7.4.3.7.1 Rest of LAMEA AI In Medical Writing Market by Type
- 7.4.3.7.2 Rest of LAMEA AI In Medical Writing Market by End Use
Chapter 8. Company Profiles
- 8.1 Parexel International (MA) Corporation
- 8.1.1 Company Overview
- 8.1.2 Recent strategies and developments:
- 8.1.2.1 Partnerships, Collaborations, and Agreements:
- 8.1.3 SWOT Analysis
- 8.2 Certara, Inc.
- 8.2.1 Company Overview
- 8.2.2 Financial Analysis
- 8.2.3 Regional Analysis
- 8.2.4 Research & Development Expenses
- 8.2.5 Recent strategies and developments:
- 8.2.5.1 Product Launches and Product Expansions:
- 8.2.5.2 Acquisition and Mergers:
- 8.2.6 SWOT Analysis
- 8.3 Accenture PLC
- 8.3.1 Company Overview
- 8.3.2 Financial Analysis
- 8.3.3 Segmental Analysis
- 8.3.4 Research & Development Expenses
- 8.3.5 SWOT Analysis
- 8.4 Smarter Dx, Inc.
- 8.5 Corti ApS
- 8.5.1 Company Overview
- 8.5.2 SWOT Analysis
- 8.6 IQVIA Holdings, Inc.
- 8.6.1 Company Overview
- 8.6.2 Financial Analysis
- 8.6.3 Segmental and Regional Analysis
- 8.6.4 SWOT Analysis
- 8.7 Abridge Al, Inc.
- 8.7.1 Company Overview
- 8.7.2 Recent strategies and developments:
- 8.7.2.1 Partnerships, Collaborations, and Agreements:
- 8.8 Syneos Health, Inc.
- 8.8.1 Company Overview
- 8.8.2 Financial Analysis
- 8.8.3 Segmental and Regional Analysis
- 8.8.4 Recent strategies and developments:
- 8.8.4.1 Partnerships, Collaborations, and Agreements:
- 8.9 IBM Corporation
- 8.9.1 Company Overview
- 8.9.2 Financial Analysis
- 8.9.3 Regional & Segmental Analysis
- 8.9.4 Research & Development Expenses
- 8.9.5 SWOT Analysis
- 8.10. Teladoc Health, Inc.
- 8.10.1 Company Overview
- 8.10.2 Financial Analysis
- 8.10.3 Regional Analysis
- 8.10.4 Research & Development Expenses
- 8.10.5 SWOT Analysis
Chapter 9. Winning Imperatives of AI In Medical Writing Market
